Introduction {#sec1-1}
============

Isoniazid (INH) is an indispensable drug in the prophylaxis and treatment of tuberculosis, but its use is associated with serious adverse effect, such as hepatotoxicity which may result in discontinuation of treatment. Hepatotoxicity with INH in its mildest form is associated with moderate elevation in liver enzymes, it occurs in 3 to 20% of patients and the severe form of hepatotoxicity is manifested as hepatic damage, especially hepatic necrosis, which occurs in 1 to 2% of patients, if not recognized early, it may be fatal.\[[@ref1][@ref2]\]

The protective actions of herbs against liver damage attract interest of many researchers; *Nigella sativa* (NS) (Black cumin) is among these herbs which are found protective for the liver against drugs or chemicals.\[[@ref3]\] Although the underlying mechanism is not well defined, the antioxidant, anti-inflammatory, and anti-angiogenesis properties of NS may play a role in this effect.\[[@ref4]--[@ref6]\] This study is aimed at investigating the possible effect of NS in protecting hepatotoxicity of INH in a rabbit model.

Materials and Methods {#sec1-2}
=====================

 {#sec2-1}

### Preparation of Nigella Sativa Dosage Form {#sec3-1}

NS seeds were purchased from a local market in Basrah. The seeds were identified and authenticated by an expert local pharmacist. Voucher specimens were kept in the Department of Pharmacology. The powder of NS was obtained by mechanical grinding of the seeds. One gram was suspended in 5 ml glucose water. A dose of 1 g/kg/day was administered to each rabbit.

### Preparation of Isoniazid Dosage Form {#sec3-2}

Two tablets of INH (200 mg) (MACLEODS Pharmaceutical Industries, Mumbai, India) were grinded by porcelain mortar, dissolved in 5 ml glucose water to obtain a concentration of (40 mg/ml). The powder of INH was completely dissolved to give a homogenized solution. The dose of INH corrected for body weight of rabbits was calculated.

### Animal Handling {#sec3-3}

The experiments were carried out on 24 locally bred sexually mature domestic male rabbits. Their body weights ranged from 1 to 1.8 kg. The animals were housed in the main animal house of the college of medicine. They were kept in a stainless steel cage for acclimatization with a 12:12-hour light/dark cycle and free access to food and drinking water. They were not fed for 12 hours before the experiment.

### Study Design {#sec3-4}

The study protocol was approved by the Institutional Ethics Committee. The study was carried out between November 2010 and September 2011.

The rabbits were randomly divided into four groups of six animals each. Group 1 (INH-treated group); the animals received starch (1 g/kg/day) daily for 12 days. INH was given at the last 2 days of the experiment in a starting loading dose of 50 mg/kg orally, then 35 mg/kg every 3 hours for three doses. Rabbits in group 2 (control group) followed the same timing steps of group 1 except substituting INH by glucose water at day 11-12 of the experiment. In rabbits in group 3 (NS + INH), the same protocol as in group 1 was followed, but starch was substituted by NS. In group 4 (NS), the rabbits received suspension of NS (as in group 3), INH was omitted and substituted by glucose water. On day 8 and for the following 3 days, according to Sarich *et al*.\'s protocol,\[[@ref7]\] phenobarbital sodium 25 mg/kg/day (Alex Pharmaceutical Industries, Alexandria, Egypt) was administered to all animals by i.p. route.

### Blood Sampling and Tissue Handling {#sec3-5}

On the morning of day 13, 5 ml of blood were taken directly from the heart under light ether anesthesia; blood was centrifuged to isolate the serum for liver function test and malondialdehyde (MDA) measurements. The rabbits were then sacrificed; liver specimens were obtained for the biological measurements and for histopathological examination.

### Histopathological Examination {#sec3-6}

The specimens were examined by a specialist histopathologist (A.S.S) at the Department of Pathology and Forensic Medicine, Basrah College of Medicine. The examiner was blinded for the treatments.

### Preparation of Liver Homogenate {#sec3-7}

Liver tissues were homogenized in cold phosphate buffer saline (pH = 7.4) to obtain 10% of liver homogenate (using Hiedolph electrical homogenizer, Korea) at 6 000 rpm for 20 minutes.

### Laboratory Measurements {#sec3-8}

### Estimation of serum malondialdehyde {#sec3-9}

Thiobarbituric acid assay of Beuge and Aust (1978)\[[@ref8]\] was used for measuring serum MDA.

### Estimation of liver malondialdehyde {#sec3-10}

MDA levels in liver homogenates were estimated as described by Ohkawa *et al*., 1979.\[[@ref9]\]

### Liver function tests {#sec3-11}

The activities of serum aspartate aminotransferase (S.AST) and serum alanine aminotransferase (S.ALT) were estimated using commercially available kits (Randox diagnostic reagents, Randox Laboratories, USA). Serum alkaline phosphatase (S.ALP) and serum total bilirubin were estimated by commercially available kits (Biolabo reagents, Biolabo SA, France).

### Statistical Analysis {#sec3-12}

SPSS computer package version 15 was used for statistical analysis. Data were analyzed by one-way ANOVA. Tukey HSD (Honestly Significant Difference) test was used to compare between the means. The differences were considered significant at *P*\<0.05. The results were expressed as mean ± SD, unless otherwise stated.

Results {#sec1-3}
=======

 {#sec2-2}

### Histopathological Examination {#sec3-13}

### The control group {#sec3-14}

There were no histopathological changes in all liver samples obtained from rabbits in this group (*n* = 6). A representative histopathological slide is presented in [Figure 1a](#F1){ref-type="fig"}.

![(a) A healthy liver tissue from a rabbit on starch and phenobarbital sodium (group 2). The central vein appears in the middle of the field. (Hematoxylin-Eosin stain, 400X). (b) A liver tissue from a rabbit receiving *Nigella sativa* and phenobarbital sodium. Portal area, bile duct, and hepatic vein are shown. The field appears clear with no sign of inflammatory cell infiltration (Hematoxylin-Eosin stain, 200X). (c) A liver tissue from a rabbit on starch and phenobarbital sodium then treated with INH (group 1). Hepatic vein is shown in the middle of the field. Moderate lymphocytic infiltration with extension of inflammation and bridging with other portal tracts (Hematoxylin-Eosin stain, 100X). (d) A liver tissue from a rabbit receiving *Nigella sativa* before phenobarbital sodium and INH treatment (group 3). The central vein and the surrounding area of the liver tissue appear normal (Hematoxylin-Eosin stain, 100X)](IJPharm-44-678-g001){#F1}

### Nigella sativa group {#sec3-15}

As in the control group, treatment with NS revealed no histopathological changes in the liver \[[Figure 1b](#F1){ref-type="fig"}\].

### INH group {#sec3-16}

There were considerable histopathological changes in all animals in this group ranging from moderate to severe hepatotoxicity. These changes were characterized by:

Inflammation of portal globular and perivenular inflammatory cell infiltration, mainly neutrophilsSinusoidal dilatation (mainly lobular)Hepatocellular necrosisModerate portal inflammation, degeneration of hepatocytes, fatty changes around central vein, marked fatty vacuolizationModerate lymphocytic infiltration with extension of inflammation and bridging with other portal tractModerate portal lymphocytic infiltration, ballooning degeneration around central vein \[[Figure 1c](#F1){ref-type="fig"}\].

### Nigella sativa + INH group {#sec3-17}

The livers appeared completely normal in three rabbits, two with mild inflammation and in one rabbit moderate inflammatory changes were observed. In the rabbits with mild histopathological changes, there was a mild portal tract inflammation, while in the rabbit with moderate changes, inflammation, perivenular degeneration of hepatocytes was seen \[[Figure 1d](#F1){ref-type="fig"}\].

### The Effect of Treatments on Serum Liver Enzymes {#sec3-18}

### The effect on aspartate aminotransferase in the serum {#sec3-19}

The mean S.AST level of the control group was 14 ± 5.1 IU/l; this was not significantly different from 14.5 ± 4.1 IU/l in NS-treated group. Treatment with INH has resulted in a significant rise in S.AST level to 36.2 ± 16.1 IU/l in comparison to the control group (*P*\<0.01) \[[Table 1](#T1){ref-type="table"}\]. Treatment with NS before INH significantly reduced S.AST level from 36.2 ± 16.1 IU/l in the INH-treated group to 13.2 ± 5.6 IU/l (*P*\<0.01) in the rabbits pretreated with NS.

###### 

The effect of pretreatment with *Nigella sativa* on INH-induced changes in serum liver enzymes in rabbits (Mean ± SD)

![](IJPharm-44-678-g002)

### The effect on alanine aminotransferase in the serum {#sec3-20}

The serum levels of ALT of the control group and the NS-treated group were 10.3 ± 3.4 IU/l and 12 ± 4.4 IU/l, respectively, which were not significantly different. There was an increase in the level of ALT to 25 ± 12.2 IU/l in the INH-treated group. This rise in ALT is significantly different from that of the control (*P*\<0.05). The level of ALT was significantly lower in the rabbits treated with NS before INH in comparison to the INH values (10.7 ± 4.5 vs 25 ± 12.2 IU/l); the difference was statistically significant (*P*\<0.05) \[[Table 1](#T1){ref-type="table"}\].

### The effect on serum alkaline phosphatase {#sec3-21}

There was an increase in S.ALP in the INH-treated rabbits compared to the control. The respective values of the control group, NS, INH, and the combination INH and NS were 75.3 ± 19.6, 77.3 ± 19.2, 102 ± 20.5, and 80.3 ± 18.8 IU/l. There were no statistical differences between them \[[Table 1](#T1){ref-type="table"}\].

### The effect on serum total bilirubin {#sec3-22}

The serum total bilirubin was (0.42 ± 0.32 mg/dl) in the control group. This level was lower in the NS-treated rabbits (0.2 ± 0.06 mg/dl) but it did not achieve statistical significance. INH treatment significantly increased total serum bilirubin to 0.98 ± 0.6 mg/dl compared to the control and NS groups \[[Table 1](#T1){ref-type="table"}\]. Treating the rabbits with NS before INH significantly lowered the total serum bilirubin to 0.25 ± 0.19 mg/dl in comparison to INH alone (*P*\<0.05).

### The Effect of Treatments on the Liver Enzymes in Liver Homogenates {#sec3-23}

### The effect on aspartate aminotransferase in liver homogenates {#sec3-24}

The mean value of AST in liver homogenates in the control group was 60 ± 7.1 IU/g. This level was 41.5 ± 19.6 IU/g in the NS-treated rabbits, which was not significantly different from control. Treatment with INH significantly increased AST in liver homogenate to 84.8 ± 12.1 IU/g in comparison to the control or NS-treated group (*P*\<0.05).

Treatment with NS before INH significantly decreased AST level in liver homogenate to 54 ± 16 IU/g in comparison to the INH value (*P*\<0.01) \[[Table 2](#T2){ref-type="table"}\].

###### 

The effect of pretreatment with *Nigella sativa* on INH-induced changes in liver enzymes of the liver homogenate in rabbits (Mean ± SD)

![](IJPharm-44-678-g003)

### The effect on alanine aminotransferase in liver homogenates {#sec3-25}

The mean value of ALT in the liver homogenate of the control group was 62 ± 16.6 IU/l \[[Table 2](#T2){ref-type="table"}\] which was not significantly different from 65.5 ± 12 IU/l in the NS-treated group. There was a small and insignificant increase in ALT in the rabbits treated with INH (75 ± 6.7 IU/l) compared to the control or the NS-treated values. However, there was marginally significant reduction (*P* = 0.053) in the level of ALT (54.5 ± 15.2 IU/l) in liver homogenate in the rabbits treated with NS prior to INH treatment in comparison to INH alone.

### The Effect of Treatments on Malondialdehyde Level {#sec3-26}

### The effect on malondialdehyde level in the liver homogenate {#sec3-27}

The mean control value of MDA in liver homogenate was 406 ± 260 ηmol/g, which was lower but statistically not significantly different from 293 ± 77.9 ηmol/g in NS.

MDA was significantly increased from 406 ± 260 in the control group to 946.3 ± 338.3 ηmol/g in the INH-treated rabbits (*P*\<0.01). Treatment with NS prior to INH administration significantly reduced MDA level to 448.5 ± 177 ηmol/g in comparison to INH alone (*P*\<0.05) \[[Table 3](#T3){ref-type="table"}\].

###### 

The effect of pretreatment with *Nigella sativa* on INH-induced changes in malondialdehyde (MDA) level in the serum and liver homogenate in rabbits (Mean ± SD)

![](IJPharm-44-678-g004)

### The effect on serum malondialdehyde level {#sec3-28}

The mean serum MDA of the control was 0.35 ± 0.26 *μ*mol/l. This was statistically not different from 0.32 ± 0.16 *μ*mol/l in the NS-treated rabbits. INH treatment increased serum MDA level to 0.938 ± 0.37 *μ*mol/l, which was significantly higher than the control or NS values (*P*\<0.05). Treatment with NS before INH decreased serum MDA to 0.373 ± 0.053 *μ*mol/l. which was significantly lower than that of INH treatment (*P*\<0.01) \[[Table 3](#T3){ref-type="table"}\].

Discussion {#sec1-4}
==========

Not many animal models that resemble INH-induced hepatotoxicity in human are available; however, Sarich *et al*. (1995)\[[@ref7]\] found the rabbits as a good and sensitive model for INH-induced hepatotoxicity. Phenobarbital sodium, an enzyme inducer, induces hepatotoxicity in more than 90% of the animals receiving INH when given before INH. Phenobarbital is not known to have hepatotoxicity and hepatoprotective effects. Practically, pretreatment with phenobarbital before INH produces hepatotoxicity in almost all animals irrespective to their acetylation status (the rabbits as human can be grouped as fast or slow acetylators for INH).\[[@ref10]\]

Treatments were given orally since oral route is the usual way of prescribing INH to human beings. INH, through this route, goes directly to the liver via the portal vein with a great exposure of the liver to INH. Once INH reaches the liver, it is metabolized to a hepatotoxic metabolite hydrazine.\[[@ref7]\]

Since INH and NS were given orally, a gap of 1.5 to 2 hours separated the administration of the two to avoid possible interaction in the GIT.

Three of the six rabbits treated with INH had slow movement, immobility, and reduced food intake. These are probably features of INH neurotoxicity. Administration of vitamin B6 in these animals was not attempted, since B6 is reported to prevent INH-induced hepatotoxicity.\[[@ref11]\]

All INH-treated rabbits had histopathological changes, the occurrence of which make comparison with other groups possible; thus, disappearance of histopathological changes by NS treatment can be interpreted as a true effect. The histopathological features of INH hepatotoxicity are characterized by focal and centrilobular inflammatory infiltration and necrosis, extension of inflammation and bridging, fatty vacuolization and ballooning degeneration also appears. Most of these changes can be seen in INH-induced hepatotoxicity in human beings, which are hardly distinguishable from histopathological features found in viral hepatitis.\[[@ref12][@ref13]\] It is worth mentioning that there were no histopathological changes in the rabbits solely treated with NS. The histopathological features in this group are not different from that in the control group. These findings support previous reports that NS is not harmful to the liver.\[[@ref6][@ref14]\]

Moreover, the results of the present study confirmed the usefulness of NS in folk medicine as liver saver,\[[@ref4]\] and also support many studies which showed NS oil extract or the aqueous suspension of the seeds as hepatoprotective against many hepatotoxins.\[[@ref6][@ref14]--[@ref16]\] None of these reports had studied NS in INH-induced hepatotoxicity. Although the mechanisms behind the hepatoprotective effects of NS are not well known, there are many possible mechanisms; NS has antioxidant properties.\[[@ref15][@ref17]\] In the present study, there was a significantly higher level of MDA, a marker of oxidative stress, in the serum and in liver homogenate in INH-treated rabbits, which is markedly declined when NS treatment is administered before INH. In addition, hepatoprotection, *in vitro* as well as *in vivo* in which antioxidant potentials of NS was suggested, was reported with thymoquinone and other active constituents of NS.\[[@ref4][@ref18]\]

Pretreatment with NS in INH-treated rabbits decreased elevated liver enzymes. These findings support the previously reported findings that NS seeds restored the enzymes level in carbon tetrachloride (CCl4)-induced hepatotoxicity in rats.\[[@ref15]\] In another study, pretreatment with thymol, an active constituent of NS, prevents any increase in liver enzymes in rodents in which hepatotoxicity was induced by CCl4 or paracetamol.\[[@ref19]\]

Another possible mechanism for the hepatoprotective effect of NS is its role in inflammation. Inflammatory changes play an important role in drug-induced acute hepatitis and products of arachidonic acid are extensively involved in the inflammatory process.\[[@ref20]\] On the other hand, it was found that the hepatotoxic metabolite of INH, hydrazine, participates in a significant production of H2O2, a cellular mediator of inflammation, which has a major role in the manifestation of adverse drug reactions.\[[@ref21]\] Thymol and thymoquinone was found to have anti-inflammatory effects;\[[@ref22][@ref23]\] thus, a hepatoprotective effect of NS due to an anti-inflammatory effect cannot be ruled out.

It can be concluded that NS powder given orally has a hepatoprotective effect against INH-induced hepatotoxicity in rabbits.
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